Nifty

:

23850.90

Sensex

:

78782.24

-453.45 (-1.87%)
-606.82 (-0.76%)

Login

Nifty
Sensex

:
:

23850.90
78782.24

-453.45 (-1.87%)
-606.82 (-0.76%)

Eiko Lifesciences Ltd.

Chemicals

Rating :

N/A

BSE: 540204 | NSE: Not Listed

Watchlist

NSE BSE

65.4

04-Nov-2024

Open
High
Low
Previous Close

70.38
71
65.13
68.55

Volume
Traded Value (lacs)
52 Week High
52 Week Low

26367
1750507
81.32
45.10

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

90.27
81.70
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

87.57
N/A
1.73

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

68.38
119.44
15.18

EBITDA CAGR (%)

10 Years
5 Years
3 Years

57.84
41.37
13.05

PAT CAGR (%)

10 Years
5 Years
3 Years

54.40
61.54
8.07

P:E (Median)

8 Years
5 Years
3 Years

92.26
91.09
96.48

P:BV (Average)

8 Years
5 Years
3 Years

1.97
1.97
1.71

EV:EBITDA (Average)

8 Years
5 Years
3 Years

40.13
36.29
34.79

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var% Dec 23 Dec 22 Var%
Net Sales 7.74 6.41 20.75% 10.75 6.51 65.13% 8.40 6.59 27.47% 6.61 4.38 50.91%
Expenses 7.39 6.06 21.95% 10.36 6.23 66.29% 7.88 6.23 26.48% 6.15 4.05 51.85%
EBITDA 0.35 0.35 0.00% 0.39 0.28 39.29% 0.52 0.36 44.44% 0.46 0.32 43.75%
EBIDTM 4.50% 5.54% 3.66% 4.23% 6.19% 5.54% 7.00% 7.43%
Other Income 0.13 0.03 333.33% 0.26 0.03 766.67% 0.11 0.21 -47.62% 0.01 0.19 -94.74%
Interest 0.04 0.06 -33.33% 0.03 0.03 0.00% 0.02 0.03 -33.33% 0.03 0.01 200.00%
Depreciation 0.16 0.16 0.00% 0.16 0.16 0.00% 0.18 0.16 12.50% 0.16 0.16 0.00%
PBT 0.28 0.16 75.00% 0.46 0.11 318.18% 0.42 0.38 10.53% 0.29 0.34 -14.71%
Tax 0.07 0.04 75.00% 0.12 0.03 300.00% 0.11 0.10 10.00% 0.05 0.09 -44.44%
PAT 0.21 0.12 75.00% 0.35 0.08 337.50% 0.31 0.28 10.71% 0.24 0.26 -7.69%
PATM 2.69% 1.87% 3.22% 1.21% 3.74% 4.29% 3.58% 5.83%
EPS 0.15 0.09 66.67% 0.25 0.06 316.67% 0.23 0.20 15.00% 0.17 0.18 -5.56%

Description Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var% Dec 23 Dec 22 Var%
Net Sales 8.15 0.00 0 10.75 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 7.73 0.00 0 10.36 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.42 0.00 0 0.39 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 5.15% 0.00% 3.66% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.13 0.00 0 0.26 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.04 0.00 0 0.03 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.16 0.00 0 0.16 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.35 0.00 0 0.46 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.09 0.00 0 0.12 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.26 0.00 0 0.35 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 3.16% 0.00% 3.22% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.22 0.00 0 0.29 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description TTM Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Net Sales 33.50 18.32 25.41 11.99 0.00 0.36 0.49 0.40 0.56 0.11 0.10 Net Sales Growth 40.23% -27.90% 111.93% 0 -100% -26.53% 22.50% -28.57% 409.09% 10.0% Cost Of Goods Sold 30.57 16.09 22.58 10.62 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Gross Profit 2.93 2.23 2.83 1.38 0.00 0.36 0.49 0.40 0.56 0.11 0.10 GP Margin 8.75% 12.17% 11.14% 11.51% 0 100% 100% 100% 100% 100% 100% Total Expenditure 31.78 17.36 24.10 11.47 0.17 0.19 0.18 0.14 0.46 0.08 0.09 Power & Fuel Cost - 0.04 0.10 0.02 0.00 0.00 0.00 0.00 0.00 0.00 0.00 % Of Sales - 0.22% 0.39% 0.17% 0 0% 0% 0% 0% 0% 0% Employee Cost - 0.23 0.23 0.12 0.07 0.02 0.07 0.06 0.10 0.00 0.00 % Of Sales - 1.26% 0.91% 1.00% 0 5.56% 14.29% 15.00% 17.86% 0% 0% Manufacturing Exp. - 0.50 0.74 0.45 0.04 0.03 0.05 0.03 0.30 0.01 0.07 % Of Sales - 2.73% 2.91% 3.75% 0 8.33% 10.20% 7.50% 53.57% 9.09% 70.0% General & Admin Exp. - 0.48 0.40 0.14 0.06 0.13 0.06 0.05 0.06 0.07 0.02 % Of Sales - 2.62% 1.57% 1.17% 0 36.11% 12.24% 12.50% 10.71% 63.64% 20.0% Selling & Distn. Exp. - 0.02 0.04 0.11 0.00 0.00 0.00 0.00 0.00 0.00 0.00 % Of Sales - 0.11% 0.16% 0.92% 0 0% 0% 0% 0% 0% 0% Miscellaneous Exp. - 0.00 0.02 0.01 0.00 0.01 0.00 0.00 0.00 0.00 0.00 % Of Sales - 0% 0.08% 0.08% 0 2.78% 0% 0% 0% 0% 0% EBITDA 1.72 0.96 1.31 0.52 -0.17 0.17 0.31 0.26 0.10 0.03 0.01 EBITDA Margin 5.13% 5.24% 5.16% 4.34% 0 47.22% 63.27% 65.00% 17.86% 27.27% 10.0% Other Income 0.51 0.85 0.67 0.46 0.43 0.02 0.02 0.00 0.02 0.00 0.00 Interest 0.12 0.16 0.48 0.09 0.07 0.03 0.05 0.02 0.00 0.00 0.00 Depreciation 0.66 0.63 0.56 0.06 0.06 0.06 0.06 0.02 0.00 0.00 0.00 PBT 1.45 1.03 0.94 0.83 0.13 0.10 0.22 0.22 0.11 0.03 0.01 Tax 0.35 0.26 0.24 0.22 0.00 0.03 0.04 0.05 0.03 0.01 0.00 Tax Rate 24.14% 25.24% 25.53% 26.51% 0.00% 30.00% 18.18% 22.73% 27.27% 33.33% 0.00% PAT 1.11 0.77 0.71 0.61 0.13 0.07 0.18 0.17 0.08 0.02 0.01 PAT before Minority Interest 1.11 0.77 0.71 0.61 0.13 0.07 0.18 0.17 0.08 0.02 0.01 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 3.31% 4.20% 2.79% 5.09% 0 19.44% 36.73% 42.50% 14.29% 18.18% 10.0% PAT Growth 50.00% 8.45% 16.39% 369.23% 85.71% -61.11% 5.88% 112.50% 300.00% 100.00% EPS 0.80 0.55 0.51 0.44 0.09 0.05 0.13 0.12 0.06 0.01 0.01

Description TTM Mar 20 Mar 19 Mar 18
Net Sales - 10.40 4.25 2.34 Net Sales Growth - 144.71% 81.62% Cost Of Goods Sold - 7.61 3.07 1.37 Gross Profit - 2.79 1.17 0.96 GP Margin - 26.83% 27.53% 41.03% Total Expenditure - 14.91 4.95 2.02 Power & Fuel Cost - 0.00 0.00 0.00 % Of Sales - 0% 0% 0% Employee Cost - 2.58 0.78 0.18 % Of Sales - 24.81% 18.35% 7.69% Manufacturing Exp. - 2.94 0.62 0.21 % Of Sales - 28.27% 14.59% 8.97% General & Admin Exp. - 1.42 0.47 0.22 % Of Sales - 13.65% 11.06% 9.40% Selling & Distn. Exp. - 0.00 0.00 0.00 % Of Sales - 0% 0% 0% Miscellaneous Exp. - 0.36 0.00 0.03 % Of Sales - 3.46% 0% 1.28% EBITDA - -4.51 -0.70 0.32 EBITDA Margin - -43.37% -16.47% 13.68% Other Income - 0.01 0.06 0.09 Interest - 0.24 0.19 0.09 Depreciation - 0.19 0.17 0.08 PBT - -4.93 -1.00 0.25 Tax - -1.31 -0.21 0.05 Tax Rate - 26.57% 21.00% 20.00% PAT - -1.91 -0.44 0.20 PAT before Minority Interest - -3.62 -0.78 0.20 Minority Interest - 1.71 0.34 0.00 PAT Margin - -18.37% -10.35% 8.55% PAT Growth - - - EPS - -1.37 -0.32 0.14

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 29.42 28.63 12.53 5.48 5.43 5.55 3.23 3.12 3.04 Share Capital 8.32 8.32 3.82 3.82 3.82 3.82 3.02 3.02 3.02 Total Reserves 21.11 20.31 2.37 1.66 1.61 1.73 0.21 0.10 0.02 Non-Current Liabilities 0.42 0.26 0.10 0.14 0.25 0.37 0.38 0.00 0.00 Secured Loans 0.00 0.05 0.13 0.20 0.26 0.31 0.37 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Liabilities 1.20 6.01 3.96 0.08 0.08 0.06 0.15 0.27 0.01 Trade Payables 1.05 1.35 1.90 0.00 0.00 0.00 0.00 0.00 0.00 Other Current Liabilities 0.11 0.12 0.09 0.06 0.07 0.05 0.05 0.00 0.00 Short Term Borrowings 0.00 4.50 1.63 0.00 0.00 0.00 0.00 0.25 0.00 Short Term Provisions 0.05 0.03 0.35 0.02 0.01 0.01 0.09 0.01 0.00 Total Liabilities 31.04 34.90 16.59 5.70 5.76 5.98 3.76 3.39 3.05 Net Block 13.88 14.29 0.25 0.31 0.37 0.43 0.49 0.00 0.00 Gross Block 15.34 15.12 0.52 0.52 0.52 0.52 0.52 0.00 0.00 Accumulated Depreciation 1.46 0.83 0.27 0.21 0.14 0.08 0.02 0.00 0.00 Non Current Assets 21.74 22.46 5.89 5.61 5.05 4.91 3.45 2.59 2.93 Capital Work in Progress 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Non Current Investment 0.05 0.20 0.22 0.50 2.13 3.58 2.45 2.59 0.26 Long Term Loans & Adv. 6.68 2.30 3.61 3.35 1.18 0.82 0.00 0.00 2.67 Other Non Current Assets 1.12 5.67 1.81 1.45 1.37 0.08 0.51 0.00 0.00 Current Assets 9.30 12.44 10.70 0.10 0.71 1.07 0.30 0.80 0.12 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 0.91 5.46 0.06 0.00 0.00 0.00 0.00 0.00 0.00 Sundry Debtors 7.11 4.56 3.41 0.00 0.08 0.00 0.00 0.00 0.10 Cash & Bank 0.61 0.22 4.07 0.02 0.03 0.73 0.01 0.51 0.02 Other Current Assets 0.68 0.02 0.40 0.08 0.59 0.33 0.29 0.28 0.00 Short Term Loans & Adv. 0.62 2.18 2.76 0.01 0.29 0.29 0.29 0.28 0.00 Net Current Assets 8.10 6.43 6.74 0.02 0.63 1.01 0.16 0.53 0.11 Total Assets 31.04 34.90 16.59 5.71 5.76 5.98 3.75 3.39 3.05

Description Mar 20 Mar 19 Mar 18
Shareholder's Funds 2.95 4.92 5.56 Share Capital 3.82 3.82 3.82 Total Reserves -0.87 1.10 1.74 Non-Current Liabilities -0.02 0.15 0.51 Secured Loans 1.61 0.42 0.48 Unsecured Loans 0.00 0.00 0.00 Long Term Provisions 0.00 0.00 0.00 Current Liabilities 9.33 4.08 4.66 Trade Payables 3.85 1.40 2.29 Other Current Liabilities 5.45 1.68 1.05 Short Term Borrowings 0.00 0.94 1.27 Short Term Provisions 0.04 0.05 0.06 Total Liabilities 10.43 9.03 10.95 Net Block 1.75 1.71 1.68 Gross Block 2.68 2.45 2.27 Accumulated Depreciation 0.93 0.74 0.58 Non Current Assets 5.39 4.86 4.98 Capital Work in Progress 0.00 0.00 0.00 Non Current Investment 0.10 1.72 3.17 Long Term Loans & Adv. 2.09 0.05 0.04 Other Non Current Assets 1.45 1.37 0.08 Current Assets 5.03 4.17 5.98 Current Investments 0.00 0.00 0.00 Inventories 3.21 2.31 3.10 Sundry Debtors 1.18 0.86 1.46 Cash & Bank 0.02 0.11 0.80 Other Current Assets 0.61 0.31 0.04 Short Term Loans & Adv. 0.47 0.58 0.57 Net Current Assets -4.30 0.09 1.32 Total Assets 10.42 9.03 10.96

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 4.22 -7.73 -0.83 0.77 -0.19 0.24 0.19 0.19 -0.05 PBT 1.03 0.94 0.83 0.13 0.10 0.22 0.22 0.11 0.03 Adjustment 0.02 0.38 -0.21 0.06 0.07 0.11 0.04 0.00 0.00 Changes in Working Capital 3.10 -8.84 -1.27 0.60 -0.33 -0.05 -0.01 0.10 -0.06 Cash after chg. in Working capital 4.15 -7.52 -0.64 0.78 -0.16 0.28 0.25 0.21 -0.04 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid 0.08 -0.21 -0.18 -0.01 -0.03 -0.04 -0.06 -0.02 -0.01 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity 0.87 0.59 -2.94 -0.65 -0.43 -1.33 -0.38 0.05 -2.75 Net Fixed Assets -0.22 -14.60 0.00 0.00 0.00 0.00 -0.52 0.00 Net Investments 0.15 0.02 0.28 1.63 1.45 -1.13 0.14 -2.33 Others 0.94 15.17 -3.22 -2.28 -1.88 -0.20 0.00 2.38 Cash from Financing Activity -4.70 3.28 7.81 -0.13 -0.08 1.82 0.15 0.25 2.80 Net Cash Inflow / Outflow 0.40 -3.85 4.05 -0.01 -0.71 0.72 -0.04 0.49 0.01 Opening Cash & Equivalents 0.22 4.07 0.02 0.03 0.73 0.01 0.05 0.02 0.01 Closing Cash & Equivalent 0.61 0.22 4.07 0.02 0.03 0.73 0.01 0.51 0.02

Description Mar 20 Mar 19 Mar 18
Cash From Operating Activity -0.33 0.16 0.00 PBT -4.93 -1.00 0.00 Adjustment 0.36 0.34 0.00 Changes in Working Capital 4.27 0.84 0.00 Cash after chg. in Working capital -0.30 0.19 0.00 Interest Paid 0.00 0.00 0.00 Tax Paid -0.02 -0.02 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 Cash From Investing Activity -0.71 -0.30 0.00 Net Fixed Assets 0.00 0.00 Net Investments 1.63 1.45 Others -2.34 -1.75 Cash from Financing Activity 0.95 -0.55 0.00 Net Cash Inflow / Outflow -0.09 -0.69 0.00 Opening Cash & Equivalents 0.11 0.80 0.00 Closing Cash & Equivalent 0.02 0.11 0.00

Financial Ratios

Standalone /

Consolidated

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 30.66 29.83 16.19 14.35 14.21 14.52 10.69 10.32 10.06 ROA 2.33% 2.74% 5.51% 2.23% 1.23% 3.75% 4.75% 2.48% 1.06% ROE 2.65% 4.05% 10.53% 2.34% 1.32% 4.16% 5.35% 2.60% 1.06% ROCE 3.77% 5.96% 9.18% 3.46% 2.25% 5.60% 6.83% 3.53% 1.60% Fixed Asset Turnover 1.20 3.25 23.28 0.00 0.71 0.96 0.77 0.00 0.00 Receivable days 116.23 57.29 103.95 0.00 84.79 0.00 0.00 0.00 213.28 Inventory Days 63.40 39.65 1.93 0.00 0.00 0.00 0.00 0.00 0.00 Payable days 27.15 26.21 32.59 0.00 0.00 0.57 0.00 0.00 0.00 Cash Conversion Cycle 152.48 70.73 73.28 0.00 84.79 -0.57 0.00 0.00 213.28 Total Debt/Equity 0.00 0.16 0.30 0.05 0.06 0.07 0.13 0.08 0.00 Interest Cover 7.57 2.98 10.35 2.90 4.11 5.83 15.45 193.44 38.70

Description Mar 20 Mar 19 Mar 18
Book Value (Rs.) 7.71 12.89 14.56 ROA -37.22% -7.85% 1.83% ROE -92.01% -14.96% 3.61% ROCE -86.53% -11.96% 4.56% Fixed Asset Turnover 4.05 1.80 1.03 Receivable days 35.79 99.91 228.50 Inventory Days 96.92 232.74 484.30 Payable days 70.22 168.32 494.04 Cash Conversion Cycle 62.50 164.33 218.75 Total Debt/Equity 0.55 0.28 0.31 Interest Cover -19.34 -4.39 3.82

Top Investors:

2b black bio llp .

ashok vishwanath hiremath

ashika global finance pvt. ltd.

v square pharmachem private limited .

joyanta kumar jana

sushila paraskumar daga

parshva kumar daga

bhavinkumar vinaychand shah

Annual Reports:

News Update:

Eiko Lifesciences - Quarterly Results
19th Oct 2024, 20:34 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback